Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Congress
Biotech
FDA rejects another ultrarare disease prospect
The biotech’s investigational product is designed to treat an extraordinarily rare genetic metabolic disorder that impacts fewer than 1,000 Americans.
Gabrielle Masson
Sep 8, 2025 10:59am
Fierce Healthcare
House Republicans propose 6% budget cut to HHS for FY2026
Sep 2, 2025 2:02pm
NIH withholding grant funds is illegal, government watchdog says
Aug 6, 2025 11:15am
Senate bill aims to keep NIH, CDC funds intact
Aug 4, 2025 11:30am
Fierce Pharma
Senate revives Orphan Cures Act in Trump's tax bill
Jun 30, 2025 10:09am
Senators grill NIH chief over proposed $18B cut
Jun 10, 2025 5:21pm